N. Keith

Most-cited papers

1. Mesenchymal Stem Cells as Therapeutic Delivery Vehicles Targeting Tumor Stroma

   N. Serakıncı, Rikke Christensen, U. Fahrioğlu, F. B. Sørensen +5 more

   2011Cancer Biotherapy and Radiopharmaceuticals37 citations

   Semantic Scholar

   Save

2. Why a Special Issue on Gene Therapy?

   N. Keith, C. Bagnis

   2003Journal of Biomedicine and Biotechnology1 citations Open access

   Semantic Scholar

   Save

3. Regenerative Futures: From Global to Local Development in 2032

   N. Keith, K. Ross, O. Wu, Sohail Ahmad +55 more

   20230 citations Open access

   Semantic Scholar

   Save

4. Financial toxicity of front-line platinum etoposide plus atezolizumab versus durvalumab in extensive-stage small-cell (ES-SCLC) lung cancer.

   Bradley W. Harrison, N. Keith, Allison Verbyla, K. Mileham

   2022Journal of Clinical Oncology0 citations

   Semantic Scholar

   Save

5. Early Phase Cancer Research in the COVID-19 Pandemic: an ECMC North Initiative

   N. Keith, R. Plummer, V. Coyle, D. Cameron +6 more

   20210 citations

   Semantic Scholar

   Save

6. A collaborative approach to exploring the future of Cancer treatment and care in relation to Precision Medicine: A design perspective.

   Kirsty Ross, N. Keith, I. Aitchison, E. Allbutt +50 more

   20190 citations

   Semantic Scholar

   Save

7. Identification of novel pyrazolopyrimidine compounds that modulate the shelterin complex and telomere length regulation via phosphoglycerate kinase 1 and stress sensor DJ1

   D. Sumpton, N. Keith, A. Bilsland

   20180 citations

   Semantic Scholar

   Save

8. Luciferase assay for modulation of the human telomerase RNA component promoter

   N. Keith, A. Bilsland

   20170 citations

   Semantic Scholar

   Save

9. Confirmatory dose-response cell survival assay for modulators of telomere damage signalling

   N. Keith, A. Bilsland

   20170 citations

   Semantic Scholar

   Save

10. Luciferase assay for modulation of the human telomerase reverse transcriptase promoter

    N. Keith, A. Bilsland

    20170 citations

    Semantic Scholar

    Save

11. Transcriptionally targeted synthetic gene medicines combine anti-cancer activity of therapeutic genes and cationic polymer to achieve long term responses in established solid tumors after systemic adminstration

    A. Schätzlein, C. Dufès, N. Keith, A. Bilsland +1 more

    20060 citations

    Semantic Scholar

    Save

12. 361 Targeted radiotherapy and gene therapy for prostate cancer: Transfection of the noradrenaline transporter gene under the control of telomerase promoters; in vitro and in vivo studies

    N. Fullerton, M. Boyd, R. Mairs, S. Ross +4 more

    20040 citations

    Semantic Scholar

    Save

13. A targeted radiotherapy/ gene therapy strategy for prostate cancer: Transfection of the noradrenaline transporter gene under the control of telomerase promoters

    N. Fullerton, M. Boyd, R. Mairs, L. Wilson +4 more

    20030 citations

    Semantic Scholar

    Save

14. Beatson International Cancer Conference--cancer: from pedigree to protein.

    V. Brunton, N. Keith

    1998British Journal of Cancer0 citations Open access

    Semantic Scholar

    Save

15. 119 P - The relative expression of EGFR and p185c-erbB-2 defines the speed of breast tumour cell proliferation

    K. W. Robertson, J. R. Reeves, N. Keith, B. Ozanne +2 more

    19960 citations

    Semantic Scholar

    Save